BRAF V600E-mutant colorectal cancer with CNS metastases treated successfully with encorafenib, binimetinib and cetuximab

This report describes a case of BRAF V600E-mutated colorectal cancer with CNS metastases in which treatment with encorafenib, binimetinib and cetuximab was effective. There is limited information on the ability of encorafenib, binimetinib and cetuximab to enter the CNS.The patient was a 53-year-old...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Toru Imai, Hirokazu Shoji, Hidekazu Hirano, Kunihito Matsuguma, Takahito Awatsu, Toshiharu Hirose, Natsuko Okita, Atsuo Takashima, Ken Kato
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Taylor & Francis Group 2024-12-01
Edice:	CNS Oncology
Témata:	binimetinib BRAF V600E central nervous system cetuximab colorectal cancer encorafenib
On-line přístup:	https://www.tandfonline.com/doi/10.1080/20450907.2024.2347824
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!